Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response.
Ontology highlight
ABSTRACT: Alterations in gut microbiota impact the pathophysiology of several diseases, including cancer. Radiotherapy (RT), an established curative and palliative cancer treatment, exerts potent immune modulatory effects, inducing tumor-associated antigen (TAA) cross-priming with antitumor CD8+ T cell elicitation and abscopal effects. We tested whether the gut microbiota modulates antitumor immune response following RT distal to the gut. Vancomycin, an antibiotic that acts mainly on gram-positive bacteria and is restricted to the gut, potentiated the RT-induced antitumor immune response and tumor growth inhibition. This synergy was dependent on TAA cross presentation to cytolytic CD8+ T cells and on IFN-γ. Notably, butyrate, a metabolite produced by the vancomycin-depleted gut bacteria, abrogated t
SUBMITTER: Uribe-Herranz M
PROVIDER: S-EPMC6934221 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA